Tuesday, December 21, 2021
Due to Emory University’s Winter Recess, the next Weekly
What’s Up in DOM Research will be sent Tuesday, January 11, 2022.
Click the button below to submit content to the weekly newsletter.
Call for RYSE Health Equity Day Committee
Tuesday, May 17, 2022
The RYSE DEI Council is seeking volunteers to serve on the 2022 Health Equity Day Committee. Health Equity Day brings together faculty, staff, and trainees from all divisions, providing a platform to share compelling new findings and identify opportunities for collaboration. The program will include equity-related presentations on clinical quality, research, education, professional development, advocacy, and outreach; a case competition; a storytelling pre-event; and a keynote address. If you are interested, please submit your name and a brief comment about your interest in the position to Jada Bussey-Jones, MD by Monday, January 3.
DOM 2022 FAME grant applications
Deadlines: Tuesday, January 18 (LOI); Monday, February 28 (Full application)
The Department of Medicine is accepting applications for its 2022 FAME (Fostering the Academic Mission in the Emory DOM) grant program, which is designed to provide support for clinical faculty to dedicate up to 20 percent of their professional time to scholarly activity including research, education, mentoring, and quality improvement projects. 2022 FAME Grant Writing Workshop Series
Friday, January 14, 21, 28, 2022 ǀ 8 - 9 a.m. ǀ Zoom
This series provides the opportunity to learn essential grant writing skills from subject matter experts. While this series is optional, it is highly encouraged. Should you choose not to attend, you are still permitted to submit a FAME grant application.
Georgia Department of Public Health Daily Status Report
View information on COVID-19 in the State of Georgia including confirmed cases, ICU admissions, hospitalizations, and deaths. Charts present the number of newly confirmed COVID-19 cases over time and are meant to aid understanding of whether the outbreak is growing, leveling off, or declining to help guide COVID-19 response. COVID-19 Vaccine Dashboard
Interactive dashboard with information about vaccines administered, vaccination by county, and race and ethnicity data.
If interested in submitting a proposal, please reach out to the DOM RAS Pre-Award Inbox at least 45 days in advance with the following information: due date, sponsor, and project duration. Please provide the RFA/PA or link from the sponsor.
Funding & Award Opportunities
Ono Pharma Breakthrough Science Initiative Awards Program
Internal Deadline: Thursday, January 13
Proposals from Principal Investigators will be considered for high-risk and high-reward science research projects which have potential to lead to science discoveries/solutions and, based on further research, to breakthrough treatments for patients. Georgia Center for Diabetes Translation Research: Pilot Project Program
Deadline: Friday, January 21 (LOI)
The purpose of this FOA is to facilitate and grow diabetes translation research at the partner institutions, within Georgia, and regionally with the overarching theme of health equity across race/ethnicity, age, sex and gender identity, geography (rural, urban), and associated comorbid conditions (e.g., cardiovascular disease, HIV, depression, Covid-19, and others). Notice of Special Interest (NOSI): Advancing Research Needed to Develop a Universal Influenza
Vaccine
Deadline: Friday, February 4, 2022
The purpose of this NOSI is to continue to foster new and innovative scientific endeavors in all areas defined in the Strategic Plan for the Development of a Universal Influenza Vaccine. NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 Independent Clinical Trial Required) (K99/R00 Independent Basic Experimental Studies with Humans Required) (K99/R00 Independent Clinical Trial Not Allowed)
Deadline: Monday, February 28, 2022
The purpose of this FOA is to facilitate a timely transition of these fellows from their mentored, postdoctoral research positions to independent tenure-track (or equivalent) faculty positions. Emily Davie and Joseph S. Kornfield Foundation Grants
Deadlines: Tuesday, March 15, July 15, and November 15, 2022
The purpose of this FOA is to support medical research in the control and treatment of pain, as well as efforts directed at enhancing individual choice in medical treatment and dying. In the last decade, the Foundation's interests have covered bioethics, palliative care, medical research and education. Notice of Intent to Publish a Funding Opportunity Announcement for Health Care Models for Persons with Multiple Chronic Conditions from Populations that Experience Health
Disparities (R01 Clinical Trials Optional)
Deadline: Friday, March 18, 2022
The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for innovative, collaborative, mutli-level and/or multi-disciplinary research designed to study the effective adaptation, integration, and implementation of recommended guidelines of care of persons with multiple chronic conditions (MCCs) from U.S. populations that experience health disparities. Notice of Special Interest (NOSI): Administrative Supplements and Urgent Competitive
Revisions for Research on the 2019 Novel Coronavirus
Deadline: Thursday, March 31, 2022
The purpose of this FOA is to highlight the urgent need for continued research on the impacts of SARS-CoV-2, the coronavirus that causes COVID-19.
Ameeta Kalokhe (Infectious Diseases) received funding from Department of Health and Human Services for a project entitled, “Ryan White Part Program Part C Outpatient Early Intervention Services Program.” Sam Lim (PI) and Cristina Drenkard (Co-I) (Rheumatology) received funding from American College of Rheumatology for a project entitled, “Developing and disseminating strategies to build sustainable lupus awareness, knowledge, skills and partnerships.” Alanna Morris (Cardiology) received funding from MYOKARDIA, Inc. for a project entitled, “An exploratory, open-label, proof of concept, phase 2A study of Mavacamten (MYK461) In participants with heart failure with preserved ejection fraction (HFpEF) and chronic elevation of cardiac troponin I and/or NT-PROBNP.” Colin Swenson (Pulmonary) received funding from Insmed Incorporated for two projects entitled, “A phase 3, randomized, double-blind, placebo-controlled study to assess the efficacy, safety, and tolerability of Brensocatib administered once daily for 52 weeks in subjects with non-Cystic Fibrosis brochiectasis - The ASPEN Study” and “ENCORE - A randomized, double-blind, placebo-controlled, active, comparator, multicenter study to evaluate the efficacy and safety of an Amikacin Liposome Inhalation Suspension (ALIS)-based regimen in adult subjects with newly diagnosed nontuberculous mycobacterial lung infection (NTM) caused by Mycobacterium avium complex (MAC)”.
Have you or a colleague recently received an award or grant funding?
The NIH grant process: From submission to notice of award
Wednesday, January 19, 2022 ǀ 10 – 11:30 a.m. ǀ Virtual
Join us as NIH experts walk through the path of a typical NIH R01 research grant from submission to summary statement to notice of award. Attendees will come away with insights into what happens at each step of the post-submission process, a better understanding of what goes into a summary statement, and what to expect with your notice of award.
Do you have an upcoming event or educational opportunity?
Justin Sprick
Post-Doctoral Fellow – Renal Medicine What is your professional background?
I completed my doctoral training in integrative physiology at the University of North Texas Health Science Center. I have been a postdoctoral fellow at Emory for the last three and a half years. My research interests and scientific expertise are broadly focused on exercise and vascular physiology in health and disease. In what division do you work, and who is your mentor?
I work in the Renal Division under the mentorship of Dr. Jeanie Park. Briefly describe your research. Why is it important?
Chronic kidney disease (CKD) patients experience exercise intolerance and exaggerated blood pressure reactivity during exercise. We seek to understand the mechanisms underlying this to make exercise both safer and more efficient in this population. We use a vast array of experimental techniques including microneurography and ultrasonography to explore how the sympathetic nervous system modulates vascular function and blood pressure responses during exercise. Further, we are exploring how combined exercise and nutritional interventions may improve exercise tolerance and vascular function. Ultimately, we hope to develop novel therapies to improve the safety and efficacy of exercise training in CKD. What do you like most about Emory?
I enjoy working alongside a diverse group of individuals comprised of both MD and PhD researchers. What is your favorite movie or TV show?
Movie: “The Pursuit of Happyness” What do you like to do in your spare time?
I enjoy cooking, being outdoors, and spending time with my wife and dog. What is a fun fact about you?
My scientific journey and interest in applied exercise physiology started 15 years ago when I was a personal fitness trainer.
"What's Up" is brought to you by Emory University's Department of Medicine Office of Research.
|